Company: ABUS
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001447028-25-000115
Chunk: 38

Company: Arbutus Biopharma Corp
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
 in the condensed consolidated statements of operations: Three Months Ended June 30,Six Months Ended June 30,2025202420252024(in thousands, except share and per share data)Stock optionsOptions granted during period762,400 424,200 4,706,122 4,163,000 Weighted average exercise price$3.34 $3.27 $3.32 $2.49 Restricted stock units (RSUs)Restricted stock units granted during period— — 901,900 1,316,200 Grant date fair value$— $— $3.29 $2.40 Stock compensation expenseResearch and development$374 $1,119 $929 $2,160 General and administrative390 2,061 1,128 3,034 Total stock compensation expense$764 $3,180 $2,057 $5,194 

11.    Segment Reporting

The Company has one reportable segment. The Company’s chief operating decision maker is the Chief Executive Officer and President. The accounting policies of the single segment are the same as those described in the summary of significant accounting policies. The chief operating decision maker assesses performance for the single segment and decides how to allocate resources based on net loss that also is reported on the condensed and consolidated statements of operations and comprehensive income (loss) as consolidated net loss. The chief operating decision maker uses net loss to monitor budget versus actual results and to evaluate the overall cash burn of the business. Three Months Ended June 30,Six Months Ended June 30,2025202420252024(in thousands)Revenue$10,739 $1,726 $12,503 $3,258 Less:Research and development employee expense, lab supplies and overhead2,297 6,908 6,733 14,008 Imdusiran IM-PROVE I, II & III clinical trials expense1,405 4,010 3,789 9,399 AB-101-001 Phase 1a/1b clinical trial expense1,738 3,186 3,637 5,996 Other early research and development programs expense58 1,447 298 1,551 General and administrative expense3,328 7,547 9,160 12,859 Restructuring expense165 — 12,538 — Other segment expense (1